Treatment of Oral Lichen Planus With Paeoniflorin and Photodynamic Therapy
Clinical Study of Combined Treatment of Oral Lichen Planus With Paeoniflorin and Photodynamic Therapy
Peking University Third Hospital
156 participants
Jul 30, 2023
INTERVENTIONAL
Conditions
Summary
Oral lichen planus (OLP) is a common chronic inflammatory disease of the oral mucosa and is considered a precancerous condition. It is characterized by white reticular changes in the oral mucosa, which can progress to erosions and cause pain in severe cases. The pathogenesis of OLP is still unclear, but it is believed to be a T-lymphocyte-mediated autoimmune disease. Currently, only symptomatic treatments are available, and there is no definitive cure. In this project, we plan to use TCM differentiation to categorize OLP patients and conduct a randomized controlled clinical trial to demonstrate the enhanced therapeutic effect of paeoniflorin combined with photodynamic therapy for OLP. The implementation of this project will provide new insights into the clinical management of OLP, improve our understanding of the treatment mechanisms, and have important theoretical and clinical implications.
Eligibility
Inclusion Criteria3
- patients with oral lichen planus
- male or female patients older than 18 years of age
- patients willing to participate with signed informed consent.
Exclusion Criteria3
- pregnant or lactating
- had serious systemic diseases of the heart, lung, liver, and kidney, or had tumors
- were unwilling to participate in the experiment.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Total glucosides of paeony capsules were given 0.6 g once, 3 times a day.
Cover the lesion with photosensitizer and fix it. Remove the photosensitizer and treat with laser diode.
Glucosides of paeony and photodynamic therapy are combined for the treatment
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05973097